The approval comes one day after the drugmaker said its vaccine is 79.34 percent effective in preventing COVID-19, citing interim analysis of phase 3 clinical trials.
Chinese citizens will be provided free vaccinations, Zeng Yixin, vice minister of China’s National Health Commission, said during a Dec. 31 news conference. The country is seeking to inoculate 50 million people with domestically developed COVID-19 vaccines before February’s Lunar New Year festivities, according to CNN.
More articles on pharmacy:
UK approves AstraZeneca’s COVID-19 vaccine
340B discounts apply to contract pharmacies, HHS clarifies
U of Missouri settles suit against former pharmacy professor accused of selling student research
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
